Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 23, 2017
Key data presented will include five-year outcomes for the WATCHMAN device as an alternative to long-term warfarin therapy for patients with non-valvular Afib.
-
Oct 4, 2017
CEO Mike Mahoney welcomed Ralls-Morrison as “an accomplished leader with deep expertise in broad-ranging legal matters and enterprise business strategy.”
-
Oct 2, 2017Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial Fibrillation
Acquisition to strengthen company's electrophysiology portfolio
-
Oct 2, 2017
Company will webcast its conference call with financial results and business highlights for Q3 ended September 30, 2017.
- Sep 25, 2017
HeartLogic is the first and only heart failure diagnostic in an implantable device shown to provide weeks of advance notice of an impending heart failure event.
-
Sep 19, 2017Data Presented at Heart Failure Society of America's 21st Annual Scientific Meeting Demonstrate Alert Improves Heart Failure Risk Prediction
Data presented demonstrate alert improves heart failure risk prediction
-
Sep 18, 2017Patients with Severe Asthma Show Sustained Clinical Improvement
Boston Scientific (NYSE: BSX) today announced results from a three year follow-up cohort in its Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma...
-
Aug 28, 2017
Boston Scientific will participate in the Morgan Stanley healthcare conference on Sept. 12, 2017. Learn how to watch the webcast or replay.
-
Aug 21, 2017
Boston Scientific will participate in the healthcare conference on September 7, 2017. Learn how to watch the webcast or replay.
-
Jul 31, 2017
Boston Scientific will participate in the investor conference on August 9, 2017. Learn how to watch the webcast or replay.
-
Jul 27, 2017
"Our strong financial performance in the first half of 2017 reflects our innovative portfolio,” said CEO Mike Mahoney.
-
Jul 5, 2017
Boston Scientific will webcast its conference call with financial results for Q2 ended June 30, 2017. Learn how to tune in or watch the replay.
-
Jun 27, 2017
Investor meeting will cover Boston Scientific’s business and long-term growth strategies, including by expanding category leadership and driving global growth.
-
Jun 6, 2017Industry's First MR-Conditional Directional DBS System with Stimulation Visualization
Industry's first MR-conditional directional DBS System with stimulation visualization
-
May 24, 2017Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference
Results from evaluation of real-world patients presented at American Thoracic Society International Conference
-
May 17, 2017
Boston Scientific will participate in the healthcare conference on May 23, 2017. Learn how to watch the webcast or replay.
-
May 16, 2017
The first head-to-head pivotal study comparing two different TAVI platforms demonstrated the LOTUS™ Valve System’s superior efficacy.
-
May 16, 2017Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
BAcquisition expands company's structural heart portfolio; increases offerings for the treatment of patients with valvular heart disease
-
May 12, 2017Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017
Largest prospective study of the WATCHMAN device presented as late-breaking trial at Heart Rhythm 2017
-
May 12, 2017Analyses Evaluated the Impact of Ethnicity, Gender and Income on Cardiovascular Outcomes
Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes
-
May 11, 2017Late-Breaker Data Presented at Heart Rhythm 2017
Late-breaker data presented at Heart Rhythm 2017
-
May 10, 2017Pivotal Data from REPRISE III and EWOLUTION Among Four Late-breaking Clinical Trials to be Presented
Pivotal data from REPRISE III and EWOLUTION among four late-breaking clinical trials to be presented
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
New devices combine longest-lasting battery technology, therapy optimization and HeartLogic™ heart failure diagnostics
-
May 3, 2017Late-Breaking Clinical Trials Feature Subcutaneous Implantable Defibrillator and WATCHMAN™ Left Atrial Appendage Closure Device
Late-breaking clinical trials feature subcutaneous implantable defibrillator (S-ICD) and WATCHMAN™ left atrial appendage closure device
-
May 1, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017 Healthcare Conference on Thursday, May 18, 2017 in Las Vegas. Susie Lisa, vice...
